Crucially, FOXO4 knockdown significantly reduced the viability of senescent TM3 Leydig cells and substantially increased their rate of apoptosis
Beyond glucose and weight loss: GLP-1 RAs reduce systemic inflammation, atherosclerosis inflammation and progression, and MACE independent of diabetes or obesity Key findings: * Using serial intravascular NIRF-OCT inflammation and IVUS imaging, liraglutide reduced plaque inflammation and plaque progression in rabbits without obesity or diabetes
Mundil, D., Cameron-Vendrig, A
It will still have to go through Phase 3 clinical trials before FDA approval
CJC-1295 no DAC was developed specifically to preserve this pulsatile pattern
Theres been some evidence that probiotics can increase GLP-1 production, per a 2024 meta-analysis